Cell and Gene Therapy Clinical Trials- Laboratory Solutions
KingMylab has supported over 500 clinical projects related to solid tumor research. Our depth of experience and quality of service, as well as our long-term collaborations with leading national and multi-national pharmaceuticals, has helped bring to market many novel Class I therapies in China. We aim to constantly improve our central laboratory capabilities to accelerate the development of innovative drugs in the ongoing fight against cancer.
Pharmacokinetics (PK) Study
Servies: CAR-T Cell Count, CAR Copy Analysis, Nucleic Acid, Carrier Detection, etc.
Platforms: Flow, LBA, PCR, etc.
Samples: Blood, Urine, Pleural Effusion, Ascites, etc.
Pharmacodynamics (PD) Study
Servies: PD Markers, etc.
Platforms: LBA, NGS, Flow, PCR, Elispot, IHC, etc.
Samples: Blood, Urine, Cerebrospinal Fluid, Thoracoabdominal Tluid, Tissue, etc.
Safety Testing
Servies: Cytokines and Inflammatory Factors, lentivirus Replication Ability, Immunogenicity, Sterility Identification, Mycoplasma Identification, etc.
Platforms: LBA, Flow, PCR, etc.
Samples: Blood, Urine, Cerebrospinal Fluid, Thoracoabdominal Fluid, etc.
Biomarker Study
Servies: Clinical Endpoint Markers, Exploratory Biomarkers, Tumor Microenvironment, etc.
Platforms: IHC, FISH, PCR, NGS, mIHC, Flow, LBA, Olink, etc.
Samples: Blood, Urine, Cerebrospinal Fluid, Thoracoabdominal Fluid, Tissue, etc.
Companion Diagnostic
Servies: Marker Confirmation and Detection, etc.
Platforms: IHC, PCR, etc.
Samples: Tissue, etc.
